BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22377920)

  • 1. Pre- and posttransplant management of solid organ transplant recipients: risk-adjusted follow-up.
    Shafaeddin Schreve B; Anliker M; Arnold AW; Kempf W; Laffitte E; Lapointe AK; Mainetti C; Pelloni F; Oberholzer P; Serra A; Streit M; Hofbauer GF;
    Curr Probl Dermatol; 2012; 43():57-70. PubMed ID: 22377920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Swiss clinical practice guidelines for skin cancer in organ transplant recipients].
    Lapointe AK; Hofbauer G; Anliker M; Arnold A; Binet I; Hunger R; Kempf W; Pascual M; Pelloni F; Serra A; Laffitte E
    Rev Med Suisse; 2010 Apr; 6(246):854-9. PubMed ID: 20455382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Swiss clinical practice guidelines for skin cancer in organ transplant recipients.
    Hofbauer GF; Anliker M; Arnold A; Binet I; Hunger R; Kempf W; Laffitte E; Lapointe AC; Pascual M; Pelloni F; Serra A;
    Swiss Med Wkly; 2009 Jul; 139(29-30):407-15. PubMed ID: 19680830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of skin cancer in solid organ transplant recipients.
    Traywick C; O'Reilly FM
    Dermatol Ther; 2005; 18(1):12-8. PubMed ID: 15842608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management.
    Tessari G; Girolomoni G
    Dermatol Surg; 2012 Oct; 38(10):1622-30. PubMed ID: 22805312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatopathology of skin cancer in solid organ transplant recipients.
    Stoff B; Salisbury C; Parker D; O'Reilly Zwald F
    Transplant Rev (Orlando); 2010 Oct; 24(4):172-89. PubMed ID: 20709518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic options to decrease actinic keratosis and squamous cell carcinoma incidence and progression in solid organ transplant recipients: a practical approach.
    Ritchie SA; Patel MJ; Miller SJ
    Dermatol Surg; 2012 Oct; 38(10):1604-21. PubMed ID: 22646842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening for skin cancer in organ transplant recipients in Denmark].
    Horn J; Lock-Andersen J; Rasmussen K; Jemec GB
    Ugeskr Laeger; 2005 Jun; 167(25-31):2762-5. PubMed ID: 16014261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin cancer in liver transplant recipients.
    Otley CC; Pittelkow MR
    Liver Transpl; 2000 May; 6(3):253-62. PubMed ID: 10827224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients.
    Alter M; Satzger I; Schrem H; Kaltenborn A; Kapp A; Gutzmer R
    J Dtsch Dermatol Ges; 2014 Jun; 12(6):480-8. PubMed ID: 24813579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cutaneous complications after organ transplantation].
    Gjersvik PJ
    Tidsskr Nor Laegeforen; 1999 Oct; 119(25):3789-92. PubMed ID: 10574059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients.
    Perera GK; Child FJ; Heaton N; O'Grady J; Higgins EM
    Br J Dermatol; 2006 May; 154(5):868-72. PubMed ID: 16634888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Skin cancer and other skin disorders in patients following solid organ transplantation].
    de Graaf YG; de Fijter JW; Posma AN; Feltkamp MC; Claas FH; Bouwes Bavinck JN
    Ned Tijdschr Geneeskd; 2005 Mar; 149(10):511-7. PubMed ID: 15782685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
    Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
    Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Organ transplant recipients need intensive control and treatment of skin cancer].
    Togsverd-Bo K; Sørensen SS; Hædersdal M
    Ugeskr Laeger; 2013 May; 175(20):1408-11. PubMed ID: 23663395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current approaches to skin cancer management in organ transplant recipients.
    Singh MK; Brewer JD
    Semin Cutan Med Surg; 2011 Mar; 30(1):35-47. PubMed ID: 21540019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.2. Cancer risk after renal transplantation. Skin cancers: prevention and treatment.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():31-6. PubMed ID: 12091640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of non-melanoma skin cancer in solid organ transplant recipients.
    Specchio F; Saraceno R; Chimenti S; Nistico S
    Int J Immunopathol Pharmacol; 2014; 27(1):21-4. PubMed ID: 24674675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of nevi in transplant patients.
    Baron J; Krol A
    Dermatol Ther; 2005; 18(1):34-43. PubMed ID: 15842611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.